Cancer Discovery

Edit Your Profile

Cancer Discovery Journal

publication venue for

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. 13:2370-2393. 2023
Differential Sensitivity of Glioma-versus Lung Cancer-Specific EGFR Mutations to EGFR Kinase Inhibitors. 2:458-471. 2012
An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR-Dependent Pathway. 1:442-456. 2011
Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy 2020
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways (vol 13, pg 2370, 2023) 2025

International Standard Serial Number (ISSN)

2159-8274

Electronic International Standard Serial Number (EISSN)

2159-8290